Search by Drug Name or NDC

    NDC 75834-0040-60 Nivanex DMX 15; 380; 10 mg/1; mg/1; mg/1 Details

    Nivanex DMX 15; 380; 10 mg/1; mg/1; mg/1

    Nivanex DMX is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 75834-0040
    Product ID 75834-040_325d6315-5d2b-49d6-b5b7-b5918c48c048
    Associated GPIs 43997303100310
    GCN Sequence Number 063944
    GCN Sequence Number Description guaifen/dextromethorphan/PE TABLET 380-15-10 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 99656
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Generic
    Proprietary Name Nivanex DMX
    Proprietary Name Suffix n/a
    Non-Proprietary Name GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 15; 380; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Nivagen Pharmaceuticals, Inc.
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2023-12-31

    Package

    NDC 75834-0040-60 (75834004060)

    NDC Package Code 75834-040-60
    Billing NDC 75834004060
    Package 60 TABLET in 1 BOTTLE (75834-040-60)
    Marketing Start Date 2014-11-24
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 9493e845-1b83-42c5-a7b5-ff3f3232e794 Details

    Revised: 2/2022